Division of Pulmonology, Allergy-Immunology, and Sleep, Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
Department of Microbiology Immunology and Biochemistry, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
Front Immunol. 2020 Jan 24;10:3058. doi: 10.3389/fimmu.2019.03058. eCollection 2019.
The underlying pathologies of sickle cell disease and asthma share many characteristics in terms of respiratory inflammation. The principal mechanisms of pulmonary inflammation are largely distinct, but activation of common pathways downstream of the initial inflammatory triggers may lead to exacerbation of both disease states. The altered inflammatory landscape of these respiratory pathologies can differentially impact respiratory pathogen susceptibility in patients with sickle cell disease and asthma. How these two distinct diseases behave in a comorbid setting can further exacerbate pulmonary complications associated with both disease states and impact susceptibility to respiratory infection. This review will provide a concise overview of how asthma distinctly affects individuals with sickle cell disease and how pulmonary physiology and inflammation are impacted during comorbidity.
镰状细胞病和哮喘的基础病理学在呼吸道炎症方面具有许多共同特征。主要的肺部炎症机制在很大程度上是不同的,但是初始炎症触发下游共同途径的激活可能导致两种疾病状态的恶化。这些呼吸道疾病改变的炎症环境可能会对镰状细胞病和哮喘患者的呼吸道病原体易感性产生不同的影响。这两种截然不同的疾病在合并症中的表现方式可能会进一步加重与两种疾病状态相关的肺部并发症,并影响呼吸道感染的易感性。这篇综述将简要概述哮喘如何明显影响镰状细胞病患者,以及在合并症期间肺部生理学和炎症如何受到影响。